OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer
Wencai Li, Zhen Wang, Jie Gao, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 1887-1896
Open Access | Times Cited: 5
Wencai Li, Zhen Wang, Jie Gao, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 1887-1896
Open Access | Times Cited: 5
Showing 5 citing articles:
Synthesis, Biological Activity, and Molecular Modelling Studies of Naphthoquinone Derivatives as Promising Anticancer Candidates Targeting COX-2
Povilas Kavaliauskas, Felipe Stambuk, Waldo Acevedo, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 541-541
Open Access | Times Cited: 16
Povilas Kavaliauskas, Felipe Stambuk, Waldo Acevedo, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 541-541
Open Access | Times Cited: 16
Analysis of the clinical efficacy and safety of computerized tomography-guided 125 I seed implantation in the treatment of non-small cell lung cancer that relapsed after chemoradiotherapy
Chuang Li, Wencai Weng, Zhe Wang, et al.
Journal of Cancer Research and Therapeutics (2022) Vol. 18, Iss. 2, pp. 426-426
Open Access | Times Cited: 6
Chuang Li, Wencai Weng, Zhe Wang, et al.
Journal of Cancer Research and Therapeutics (2022) Vol. 18, Iss. 2, pp. 426-426
Open Access | Times Cited: 6
Stereotactic body radiotherapy for mediastinal lymph node with CyberKnife®: Efficacy and toxicity
A. Camps-Maléa, Y. Pointreau, S. Chapet, et al.
Cancer/Radiothérapie (2023) Vol. 27, Iss. 3, pp. 225-232
Open Access | Times Cited: 1
A. Camps-Maléa, Y. Pointreau, S. Chapet, et al.
Cancer/Radiothérapie (2023) Vol. 27, Iss. 3, pp. 225-232
Open Access | Times Cited: 1
Long-term Progression-free Survival With Pemetrexed Plus Bevacizumab in NSCLC Patients
SHIGEN HAYASHI, Kunihiko Miyazaki, Toshihiro Shiozawa, et al.
Cancer Diagnosis & Prognosis (2023) Vol. 3, Iss. 3, pp. 377-382
Open Access
SHIGEN HAYASHI, Kunihiko Miyazaki, Toshihiro Shiozawa, et al.
Cancer Diagnosis & Prognosis (2023) Vol. 3, Iss. 3, pp. 377-382
Open Access
Construction and Validation of a Recurrent Risk Nomogram Model for Non-Small Cell Lung Cancer within 1 Year after Radical Resection
Dechuang Zeng, Xiqiang Tang, Feng Nong, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-8
Open Access
Dechuang Zeng, Xiqiang Tang, Feng Nong, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-8
Open Access
